Schedule 13D ownership disclosure
NGM BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 62921N105
Event date: 2019-05-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-150602
- Form type
- SC 13D
- Filer
- COLUMN GROUP L P
- CIK
- CIK 1347769
- Filed
- May 17, 2019
- Reporting period
- May 07, 2019
- Description
- Schedule 13D beneficial ownership